Showing posts with label fda news digest. Show all posts
Showing posts with label fda news digest. Show all posts

Friday, August 15, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

Update: 1

From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Thu, 14 Aug 2008 14:04:21 -0500 (CDT)
Subject: Hop Lee Trading Co., Inc. Issues Alert on Undeclared Sulfites in Flower Brand Dried Sweet Potato (August 12)

Hop Lee Trading Co., Inc. Issues Alert on Undeclared Sulfites in Flower Brand Dried Sweet Potato (August 12)
Thu, 14 Aug 2008 13:28:00 -0500

Hop Lee Trading Co. Inc. is recalling Flower brand Dried Sweet Potato because it contains undeclared sulfites. Consumers who have severe sensitivity to sulfites run the risk of serious or life-threatening allergic reactions if they consume this product.


Update: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Thu, 14 Aug 2008 14:24:29 -0500 (CDT)
Subject: Boston Scientific NexStent Monorail Recall - Medical Device Safety

Boston Scientific has recalled the NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System due to the possibility that the tip of the stent delivery system may detach during the procedure.


Update: 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Thu, 14 Aug 2008 13:07:17 -0500 (CDT)
Subject: FDA MedWatch - July 2008 Drug Safety-Related Labeling Changes for 35 Drugs Now Available on Web

MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

The July 2008 posting includes 35 drug products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, and PATIENT PACKAGE INSERTS, and MEDICATION GUIDES.

The "Summary Page" provides a listing of drug names and safety labeling sections revised:

http://www.fda.gov/medwatch/safety/2008/jul08_quickview.htm

The "Detailed View Page" identifies safety labeling sections and subsections revised along with a brief summary of new or modified safety information to the BOXED WARNING, CONTRAINDICATIONS, and/or WARNINGS sections:

http://www.fda.gov/medwatch/safety/2008/jul08.htm

In July 2008, the following drugs had modifications to the BOXED WARNING section:

Baraclude (entecavir) Tablets and Oral Solution

Exforge (amlodipine and valsartan) Tablets

Strattera (atomoxetine hydrochloride) Capsules

Tykerb (lapatinib) Tablets

Ziagen (abacavir sulfate) Tablets and Oral Solution

In addition, the following products in July 2008 had changes to MEDICATION GUIDES:

Advair HFA (fluticasone propionate and salmeterol) Inhalation Aerosol for Oral Inhalation Only

Enbrel (etanercept) for Subcutaneous Injection

EC-Naprosyn (naproxen delayed-release tablets), Naprosyn (naproxen tablets), Anaprox/Anaprox DS (naproxen sodium tablets), and Naprosyn (naproxen suspension)

Strattera (atomoxetine hydrochloride) Capsules

Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for Oral Inhalation Only

Vicoprofen (hydrocodone bitartrate/ibuprofen) Tablets

Ziagen (abacavir sulfate) Tablets and Oral Solution


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Thursday, August 14, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

Update: 1

From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 13 Aug 2008 08:02:48 -0500 (CDT)
Subject: Enforcement Report for August 13, 2008

Enforcement Report for August 13, 2008
Wed, 13 Aug 2008 05:33:00 -0500

Weekly report by the Food and Drug Administration, Department of Health and Human Services. It contains information on actions taken in connection with agency Regulatory activities.


Update: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 13 Aug 2008 08:34:29 -0500 (CDT)
Subject: CDRH New Update

Skip NavigationFDA Logo links to FDA home pageCenter for Devices and Radiological Health, U.S. Food and Drug AdministrationHHS Logo links to Department of Health and Human Services website

FDA Home Page | CDRH Home Page | Search | A-Z Index U.S. Food and Drug AdministrationCenter for Devices and Radiological Health Questions?
horizonal rule
CDRHNEW Logo Date: August 13, 2008

The following new items were added to the CDRH web pages on August 12, 2008. Previous CDRH New Items can be found on the CDRHNew Page.

* Orthopaedic and Rehabilitation Devices Panel Advisory Meeting, July 15, 2008 - Transcripts Text

---


Update: 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 13 Aug 2008 08:55:35 -0500 (CDT)
Subject: FDA Warning Letters Update

You are subscribed to FDA Warning Letters for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.


Update: 4
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Wed, 13 Aug 2008 12:03:11 -0500 (CDT)
Subject: FDA Law Enforcers Crack Down on Illegal Botox Scammer

FDA Law Enforcers Crack Down on Illegal Botox Scammer
Wed, 13 Aug 2008 11:16:00 -0500

FDA's Office of Criminal Investigations found physicians who put profit before patients when they injected them with fake Botox Cosmetic.


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Wednesday, August 13, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

Update: 1

From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 12 Aug 2008 07:02:32 -0500 (CDT)
Subject: Drug Shortages: Current Drug Shortages; Phospholine Iodide, Ophthalmic solution

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

Drug Shortages: Current Drug Shortages; Phospholine Iodide, Ophthalmic solution
Fri, 08 Aug 2008 15:08:00 -0500

See Web site for additional information on this Current Drug Shortage


Update: 2
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 12 Aug 2008 09:09:37 -0500 (CDT)
Subject: FDA Consumer Education about Medicine

You are subscribed to FDA Consumer Education about Medicine for U.S. Food & Drug Administration (FDA). This information has recently been updated, and is now available.

"Tips for Talking with Your Pharmacist - to learn how to use medicines safely." Tips to help you in the pharmacy -- what to tell and ask your pharmacist, and what to do after you get the medicine from your pharmacist. Available in html or a printable, high resolution PDF version.

It's linked off the "Consumer Education-Ensuring Safe Use of Medicine" page at http://www.fda.gov/cder/consumerinfo/ensuring_safe_use_text.htm, or you can go directly to it at: http://www.fda.gov/cder/consumerinfo/stop_learn_go_pharmacist.htm.


Update: 3
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 12 Aug 2008 13:03:15 -0500 (CDT)
Subject: Home Made Brand Foods Recalls Tuna Salad Because of Possible Health Risk (August 11)

Home Made Brand Foods Recalls Tuna Salad Because of Possible Health Risk (August 11)
Tue, 12 Aug 2008 12:39:00 -0500

Home Made Brand Foods is voluntarily recalling approximately 4890 pounds of Ready-to-Eat Tuna Salad with an expiration date of 8/19/08. This product has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems.


Update: 4
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 12 Aug 2008 14:03:08 -0500 (CDT)
Subject: Potential Problems at Two Baltimore Pharmacies

Potential Problems at Two Baltimore Pharmacies
Tue, 12 Aug 2008 13:02:00 -0500

FDA is warning consumers who filled prescriptions at The Medicine Shoppe pharmacies located at 8035A Liberty Road and 5900 Reisterstown Road in Baltimore that they may have received drugs that were either expired or suspected counterfeit.


Update: 5
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 12 Aug 2008 16:47:33 -0500 (CDT)
Subject: CDER New 7/12/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

August 12, 2008

  • FDA issues an Information for Healthcare Professionals sheet for Naltrexone. Drug Information.
  • New and Generic Drug Approvals
    • Ak-Fluor (fluorescein sodium) Injection, Akorn, Inc., Approval
    • Cefazolin Injection, Aurobindo Pharma, Ltd., Approval
    • Zovirax (acyclovir) Capsules, GlaxoSmithKline, Labeling Revision
    • Zovirax (acyclovir) Oral Suspension, GlaxoSmithKline, Labeling Revision
    • Zovirax (acyclovir) Tablets, GlaxoSmithKline, Labeling Revision


Update: 6
From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Tue, 12 Aug 2008 14:19:04 -0500 (CDT)
Subject: FDA MedWatch -Vivitrol (naltrexone)- Serious Injection Site Reactions May Occur

MedWatch logo MedWatch - The FDA Safety Information and Adverse Event Reporting Program

FDA informed healthcare professionals of the risk of adverse injection site reactions in patients receiving naltrexone. Naltrexone is indicated for the treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment. Naltrexone is administered as an intramuscular gluteal injection and should not be administered intravenously, subcutaneously, or inadvertently into fatty tissue. Physicians should instruct patients to monitor the injection site and contact them if they develop pain, swelling, tenderness, induration, bruising, pruritus, or redness at the injection site that does not improve or worsens within two weeks. Physicians should promptly refer patients with worsening injection site reactions to a surgeon. Read the FDA recommendations for healthcare professionals to consider regarding the use of Naltrexone injection.

Read the entire MedWatch Safety Summary, including a link to the FDA Drug Information Page regarding this issue at:
http://www.fda.gov/medwatch/safety/2008/safety08.htm#naltrexone


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Tuesday, August 12, 2008

U.S. Food & Drug Administration (FDA) Daily Digest Bulletin

Update: 1

From: "U.S. Food & Drug Administration (FDA)" <fda@service.govdelivery.com>
Date: Mon, 11 Aug 2008 14:28:51 -0500 (CDT)
Subject: CDER New 8/11/2008

FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

CDERnew Logo

August 11, 2008

  • New and Generic Drug Approvals
    • Azor (amlodipine besylate and olmesartan medoxomil) Tablets, Daiichi Sankyo, Inc., Labeling Revision
    • Cefepime Injection, Baxter Healthcare Corp., Approval
    • Cialis (tadalafil) Tablets, Eli Lilly and Co., Labeling Revision
    • Corzide (bendroflumethiazide and nadolol) Tablets, King Pharmaceuticals, Labeling Revision
    • Femara (letrozole) Tablets, Novartis Pharmaceuticals Corp., Labeling Revision
    • Kerlone (betaxolol hydrochloride) Tablets, Sanofi-Aventis US, LLC, Labeling Revision
    • Ramipril Capsules, Cipla Ltd, Approval
    • Talacen (acetaminophen and pentazocine hydrochloride) Tablets, Sanofi-Aventis US, LLC, Labeling Revision


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420

Monday, August 11, 2008

FDA News Digest for August 11, 2008


FDA News Digest

August 11, 2008

_____________________________________

IN THIS WEEK'S ISSUE

» News

-- Flu Vaccines Approved for 2008-2009 Season

-- 'FDA Patient Safety News' Video, Podcast Available

» Safety Alerts/Recalls

» Upcoming Public Meetings

» Consumer Health Information

__________________________________________

NEWS

Correction: In last week's issue, a news item about a report that identifies factors related to FDA approval decisions in first-cycle product reviews included an incorrect link for viewing the report. The correct link is http://www.fda.gov/oc/pdufa3/firstcyclerept08/default.htm.

Flu Vaccines Approved for 2008-2009 Season

FDA has approved this year's seasonal influenza vaccines that include new strains of the virus likely to cause flu in the United States during the 2008-2009 season. This season's vaccines contain three strains of the influenza virus that disease experts expect to be the most likely cause of the flu in the United States.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01872.html

'FDA Patient Safety News' Video, Podcast Available

FDA has posted the latest edition of "FDA Patient Safety News," a free Web-based video news program. Aimed primarily at health professionals, the program features information on new drugs, biologics, and medical devices, as well as FDA safety notifications and product recalls.

-- To view video or text version: http://www.fda.gov/psn

-- To access Podcast: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/psn/podcast.cfm

To view an archive of recent FDA news releases, go to

To access the RSS feed of FDA news releases, go to

http://www.fda.gov/bbs/topics/news/rssPress.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

_____________________________________________

SAFETY ALERTS/RECALLS

For a complete list of recalls, market withdrawals, and safety alerts involving FDA-regulated

products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html.

To access the RSS feed of FDA recalls information, go to

http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

____________________________________________________________________

UPCOMING PUBLIC MEETINGS

Sept. 8-10 -- Parenteral Drug Association (PDA)/FDA Joint Regulatory Conference

Location: Washington, D.C.

http://www.pda.org/webmodules/webarticles/templates/new_conferences_2008_PDA_FDA.aspx?articleid=1453&zoneid=190

Sept. 10-12 -- Parenteral Drug Association (PDA)/FDA Pharmaceutical Ingredient Supply Chain Conference

Location: Washington, D.C.

http://www.pda.org/webmodules/webarticles/templates/2008_PDA-FDA_Pharmaceutical_Ingredient_Supply_Chain_Conference.aspx?articleid=1803&zoneid=233

For a complete list of upcoming meetings, seminars, and other public events sponsored

or co-sponsored by FDA, go to http://www.fda.gov/opacom/hpmeetings.html.

CONSUMER HEALTH INFORMATION

Consumer updates in the spotlight this week are:

› Law Enforcers Protect Consumers' Health

http://www.fda.gov/consumer/updates/oci072307.html

› FDA 101: Dietary Supplements

http://www.fda.gov/consumer/updates/supplements080408.html

To receive all consumer updates by e-mail, go to http://www.fda.gov/consumer/consumerenews.html.

For the latest in consumer health news from FDA, visit http://www.fda.gov/consumer/default.htm.

Check out "Andy's Take," a commentary from FDA's commissioner.

Go to http://www.fda.gov/oc/vonEschenbach/andys_take/default.html

_____________________________________________________________

Thanks for subscribing to FDA News Digest.

Our next issue will be sent August 18.

Comments about FDA News Digest?

Send an e-mail to fdanewsdigest@oc.fda.gov.


This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420